• Asia’s Longest Running Generics Event
  •  Venturing into R&D & Partnerships
  •   Innovative Models for Sustainable Growth in Asia

The past decade has witnessed significant growth and stern competition amongst generic pharmaceutical companies. This trend is likely to continue with tightened regulations and a patent cliff in the years ahead. IBC’s Generics 2014 is into its 9th year with a new agenda to unlock key concerns through interactive sessions. The conference is a perfect opportunity to gain critical insights on strategic partnerships, marketing planning, investment opportunities in supergenerics, biosimilar challenges, innovative technology and streamlined manufacturing best practices from MNC and regional generics companies.

Key Conference Themes Addressed in 2014

  • Global Generic Market Trends and Regulatory Updates
  • Strategic Partnership and Collaboration
  • Venturing into Supergenerics and Biosimilars
  • Strategic Marketing Planning and Branding
  • Investing in R&D and New Means of Growth
  • Innovative Technology and Quality Manufacturing

Last Year’s Speaker’s Included

Shanti Shamdasani
Regional Director Government Affairs – ASEAN, Johnson & Johnson
Jose Ochave
Senior Vice President, Business Development, Unilab
Jingyi Yu
Manager, Generics & Biosimilar Business, Strategy & Business Development, Pfizer
Debbie Pangan
Corporate Affairs Director
The Generics Pharmacy

Produced by